Literature DB >> 10598761

Stinging and rosacea.

S B Lonne-Rahm1, T Fischer, M Berg.   

Abstract

A total of 32 rosacea patients (25 with the papulopustular type of rosacea and 7 with the erythematotelangiectatic type) and 32 healthy persons were single-blind tested with a solution of 5% lactic acid and pure water applied to their cheeks. Twenty-four patients and 6 controls reacted positively as "stingers" (p<0.001) in this objective test of sensitive skin. All 7 of the patients with erythematotelangiectatic rosacea, but only 17/25 with the papulopustular type, were stingers (n.s.). The reason why some patients react with subjective symptoms, such as itching, burning, stinging, prickling or tingling, is unclear. The findings in this study are not surprising, but do support the theory that impairment due to different stimuli, most likely because of vascular sensitivity, is a central mechanism in the aetiology of rosacea. The correlation between sensitive vessels and sensitive skin has, however, not yet been determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598761     DOI: 10.1080/000155599750009915

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  13 in total

1.  The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin.

Authors:  James Q Del Rosso; Jacqueline Levin
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

2.  Comprehensive medical management of rosacea: an interim study report and literature review.

Authors:  James Q Del Rosso; Eric W Baum
Journal:  J Clin Aesthet Dermatol       Date:  2008-05

Review 3.  Multivesicular Emulsion Ceramide-containing Moisturizers: An Evaluation of Their Role in the Management of Common Skin Disorders.

Authors:  Joshua A Zeichner; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-12-01

4.  Clinical evaluation of 168 korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype.

Authors:  You In Bae; Sook-Jung Yun; Jee-Bum Lee; Seong-Jin Kim; Young Ho Won; Seung-Chul Lee
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

5.  Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

Authors:  J Fowler; M Jarratt; A Moore; K Meadows; A Pollack; M Steinhoff; Y Liu; M Leoni
Journal:  Br J Dermatol       Date:  2012-03       Impact factor: 9.302

6.  A Guide to the Ingredients and Potential Benefits of Over-the-Counter Cleansers and Moisturizers for Rosacea Patients.

Authors:  Jacquelyn Levin; Richard Miller
Journal:  J Clin Aesthet Dermatol       Date:  2011-08

Review 7.  The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review.

Authors:  Martin Schaller; Thomas Dirschka; Sol-Britt Lonne-Rahm; Giuseppe Micali; Linda F Stein Gold; Jerry Tan; James Del Rosso
Journal:  Acta Derm Venereol       Date:  2021-10-31       Impact factor: 3.875

Review 8.  Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies.

Authors:  Anna D Holmes; Kimberly A Waite; Michael C Chen; Kiruthi Palaniswamy; Thomas H Wiser; Zoe D Draelos; Elyse S Rafal; W Philip Werschler; Alison E Harvey
Journal:  J Clin Aesthet Dermatol       Date:  2015-08

9.  Skincare Habits and Rosacea in 3,439 Chinese Adolescents: A University-based Cross-sectional Study.

Authors:  Zhihong Zuo; Ben Wang; Minxue Shen; Hongfu Xie; Ji Li; Xiang Chen; Yiya Zhang
Journal:  Acta Derm Venereol       Date:  2020-03-12       Impact factor: 3.875

10.  Preliminary open-label clinical evaluation of the soothing and reepithelialization properties of a novel topical formulation for rosacea.

Authors:  Adele Sparavigna; Beatrice Tenconi; Ileana De Ponti
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.